Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

NCT00545142 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Abilify(Aripiprazole)
DRUG: Depakote(Divalproate)

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.